Company Filing History:
Years Active: 2011
Title: The Innovative Mind of Hironori Oosaki
Introduction
Hironori Oosaki, an esteemed inventor based in Tsukuba, Japan, has made significant strides in the field of drug design and screening methods. With expertise in identifying target proteins and genes, his contributions pave the way for the development of novel bioactive substances that hold promise for pharmaceuticals.
Latest Patents
Oosaki holds a remarkable patent titled "Target protein and target gene in drug designing and screening method." This patent delineates a comprehensive approach to identifying target proteins and genes associated with bioactive substances such as drugs. The invention introduces innovative screening methods for substances that can regulate various bioactivities, as well as techniques for producing bioactive substance derivatives. It also encompasses complex formations between bioactive substances and target proteins, alongside determination methods and kits for assessing disease susceptibility and onset risk.
Career Highlights
Currently, Oosaki is affiliated with the Reverse Proteomics Research Institute Co., Ltd., where he leverages his research to advance the field of proteomics. Through his work, he aims to bridge the gap between biological research and practical applications in drug development.
Collaborations
Throughout his career, Oosaki has collaborated with notable colleagues such as Yorimasa Suwa and Tadakazu Yamauchi. These partnerships have fostered an environment of innovation and knowledge-sharing that is crucial in the pursuit of groundbreaking advancements in bioactive research.
Conclusion
Hironori Oosaki's innovative contributions to drug design and screening reveal the potential for transformative impacts on public health. His work not only showcases the significance of targeting specific proteins and genes but also exemplifies the collaborative spirit inherent in scientific research, setting a precedent for future inventors in the field.